Intellus Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.6K Buy
+38,232
New +$156K 0.01% 152

Other funds holding KPTI

Intellus Advisors's KPTI Position: Q3 2026 in Review

Intellus Advisors opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 38,232 shares worth $46.6K. The stake represents 0.01% of the portfolio and ranks #152 among its holdings.

92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

  • Intellus Advisors held 38,232 shares of Karyopharm Therapeutics worth $46.6K as of Q3 2026.
  • Karyopharm Therapeutics was a new Intellus Advisors position in Q3 2026.
  • Karyopharm Therapeutics made up 0.01% of Intellus Advisors's portfolio in Q3 2026, its #152 holding.
  • 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on Intellus Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.